Hemoglobin Testing Market, by Technology (Chromatography, Immunoassay, Others) and, by End User (Hospitals, Research Centers, Laboratories): Global Opportunity Analysis and Industry Forecast, 2023-2032

Hemoglobin is a protein found in the red blood cells (RBCs) that carries out oxygen transportation throughout the body. Hemoglobin tests are carried out to measure the amount of hemoglobin present in the blood. These tests are usually performed during complete blood count as a routine health checkup or to determine the presence of any disease, which could occur due to low count of RBCs. Patients commonly undergo hemoglobin test due to reasons such as fatigue, poor health, or unexplained weight loss. The centralized hemoglobin testing methods are useful for the diagnosis of diabetes and anemia.

In home care testing, the laboratories send a professional person to the patients doorstep for blood sample collection and there is no need to visit laboratories or hospitals for tests. After the tests are conducted, the results are electronically sent back to the patient.

As most patients prefer home care testing to laboratories, there is growth in demand for direct-to-consumer testing, which is a major factor that drives the market growth. Moreover, the emergence of advanced techniques has improved the ease of testing and provides quick test results. Hence, the development of advanced hemoglobin testing devices is further expected to boost the market growth during the forecast period. However, high cost and maintenance associated with hemoglobin testing may hinder the market growth.

The global hemoglobin testing market is segmented based on technology, end user, and geography. Based on technology, it is divided into chromatography, immunoassay, and other. Based on end user, it is categorized into hospitals, research centers, and laboratories. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major players, such as Abbott Laboratories, ACON Laboratories, Alere, Bayer Medical Care, Bio-Rad Laboratories, Danaher, EKF Diagnostics Holdings, F. Hoffmann-La Roche, Siemens Healthcare, and Thermo Fisher Scientific, are also provided in this report.

Key Benefits

• This report provides an extensive analysis of the current and emerging market trends and dynamics in the global hemoglobin testing market to identify the prevailing market opportunities.
• The projections in this report are made by analyzing the current trends and future market potential in terms of value.
• Competitive intelligence helps to understand the competitive scenario across the geographies.
• An in-depth analysis of current research and clinical developments within market is provided with key dynamic factors that help understand the market behavior.

  Hemoglobin Testing Market, by Technology Report Highlights

Aspects	Details
By Technology	Chromatography Immunoassay Others
By End User	Hospitals Research Centers Laboratories
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	F. Hoffmann-La Roche, Bio-Rad Laboratories, Alere, ACON Laboratories, Danaher Corporation, Bayer Medical Care, Abbott Laboratories, EKF Diagnostics Holdings, Siemens Healthcare, Thermo Fisher Scientific Inc.

^*Terms and Conditions Apply